Cetirizine EP Impurity B (HCl Salt)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1000690-91-4Cetirizine EP Impurity B (HCl Salt)

● In Stock

Catalogue No.:VL330002
CAS No.:1000690-91-4
Mol. Formula:C19H23Cl3N2O2
Mol. Weight:417.76 g/mol

Additional information on CAS 1000690-91-4

Parent drug

Cetirizine

IUPAC Name

(RS)-2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1- yl]acetic acid dihydrochloride

Pharmacopoeial Synonyms

N/A

Other Synonyms

Cetirizine Acetic Acid dihydrochloride; Levocetirizine Impurity B dihydrochloride; 4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineacetic Acid Dihydrochloride

Smile

O=C(O)CN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.[H]Cl.[H]Cl

InChI

InChI=1S/C19H21ClN2O2.2ClH/c20-17-8-6-16(7-9-17)19(15-4-2-1-3-5-15)22-12-10-21(11-13-22)14-18(23)24;;/h1-9,19H,10-14H2,(H,23,24);2*1H

Description

Cetirizine EP Impurity B (2HCl salt), also known as Cetirizine Acetic Acid dihydrochloride ; Levocetirizine Impurity B dihydrochloride ;4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineacetic Acid Dihydrochloride is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Cetirizine. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url